352 related articles for article (PubMed ID: 9398285)
21. Catalytic folding of the Cepsilon3 domain by its high affinity receptor.
Harwood NE; Price NC; McDonnell JM
FEBS Lett; 2006 Apr; 580(8):2129-34. PubMed ID: 16563391
[TBL] [Abstract][Full Text] [Related]
22. Fine epitope mapping of humanized anti-IgE monoclonal antibody omalizumab.
Zheng L; Li B; Qian W; Zhao L; Cao Z; Shi S; Gao J; Zhang D; Hou S; Dai J; Wang H; Guo Y
Biochem Biophys Res Commun; 2008 Oct; 375(4):619-22. PubMed ID: 18725193
[TBL] [Abstract][Full Text] [Related]
23. The mechanism of binding staphylococcal protein A to immunoglobin G does not involve helix unwinding.
Jendeberg L; Tashiro M; Tejero R; Lyons BA; Uhlén M; Montelione GT; Nilsson B
Biochemistry; 1996 Jan; 35(1):22-31. PubMed ID: 8555177
[TBL] [Abstract][Full Text] [Related]
24. Unsusceptibility of recombinant human Fc fragments of immunoglobulin E to thrombin.
Kamiya T
Hum Antibodies Hybridomas; 1996; 7(1):42-7. PubMed ID: 8886836
[TBL] [Abstract][Full Text] [Related]
25. Utilizing Fcepsilon-Bak chimeric protein for studying IgE-FcepsilonRI interactions.
Belostotsky R; Lorberboum-Galski H
Clin Immunol; 2004 Jan; 110(1):89-99. PubMed ID: 14962800
[TBL] [Abstract][Full Text] [Related]
26. Role of glycosylation sites in the IgE Fc molecule.
Nettleton MY; Kochan JP
Int Arch Allergy Immunol; 1995; 107(1-3):328-9. PubMed ID: 7613162
[TBL] [Abstract][Full Text] [Related]
27. Suppression of mast cell degranulation through a dual-targeting tandem IgE-IgG Fc domain biologic engineered to bind with high affinity to FcγRIIb.
Cemerski S; Chu SY; Moore GL; Muchhal US; Desjarlais JR; Szymkowski DE
Immunol Lett; 2012 Mar; 143(1):34-43. PubMed ID: 22305932
[TBL] [Abstract][Full Text] [Related]
28. Identification of the high affinity receptor binding region in human immunoglobulin E.
Helm BA; Sayers I; Higginbottom A; Machado DC; Ling Y; Ahmad K; Padlan EA; Wilson AP
J Biol Chem; 1996 Mar; 271(13):7494-500. PubMed ID: 8631779
[TBL] [Abstract][Full Text] [Related]
29. Affinity improvement of the high-affinity immunoglobulin E receptor by phage display.
Iwasaki A; Doi T; Umetani M; Watanabe M; Suda M; Hattori Y; Nagoya T
Biochem Biophys Res Commun; 2002 Apr; 293(1):542-8. PubMed ID: 12054635
[TBL] [Abstract][Full Text] [Related]
30. Structure of the human IgE-Fc C epsilon 3-C epsilon 4 reveals conformational flexibility in the antibody effector domains.
Wurzburg BA; Garman SC; Jardetzky TS
Immunity; 2000 Sep; 13(3):375-85. PubMed ID: 11021535
[TBL] [Abstract][Full Text] [Related]
31. A fluorescent biosensor reveals conformational changes in human immunoglobulin E Fc: implications for mechanisms of receptor binding, inhibition, and allergen recognition.
Hunt J; Keeble AH; Dale RE; Corbett MK; Beavil RL; Levitt J; Swann MJ; Suhling K; Ameer-Beg S; Sutton BJ; Beavil AJ
J Biol Chem; 2012 May; 287(21):17459-17470. PubMed ID: 22442150
[TBL] [Abstract][Full Text] [Related]
32. Automated hydrodynamic modelling of a complex between a human IgE fragment (Fc epsilon 3-4) and the IgE high affinity receptor Fc epsilon RI alpha-chain.
Beavil AJ; Beavil RL
Eur Biophys J; 1997; 25(5-6):463-9. PubMed ID: 9188169
[TBL] [Abstract][Full Text] [Related]
33. IgE-binding properties and selectivity of peptide mimics of the FcvarepsilonRI binding site.
Sandomenico A; Monti SM; Marasco D; Dathan N; Palumbo R; Saviano M; Ruvo M
Mol Immunol; 2009 Oct; 46(16):3300-9. PubMed ID: 19699527
[TBL] [Abstract][Full Text] [Related]
34. Basis of the 1:1 stoichiometry of the high affinity receptor Fc epsilon RI-IgE complex.
Keown MB; Ghirlando R; Mackay GA; Sutton BJ; Gould HJ
Eur Biophys J; 1997; 25(5-6):471-6. PubMed ID: 9188170
[TBL] [Abstract][Full Text] [Related]
35. The Fc segment of IgE influences the kinetics of dissociation of a symmetrical bivalent ligand from cyclic dimeric complexes.
Subramanian K; Holowka D; Baird B; Goldstein B
Biochemistry; 1996 Apr; 35(17):5518-27. PubMed ID: 8611543
[TBL] [Abstract][Full Text] [Related]
36. Trapping IgE in a closed conformation by mimicking CD23 binding prevents and disrupts FcεRI interaction.
Jabs F; Plum M; Laursen NS; Jensen RK; Mølgaard B; Miehe M; Mandolesi M; Rauber MM; Pfützner W; Jakob T; Möbs C; Andersen GR; Spillner E
Nat Commun; 2018 Jan; 9(1):7. PubMed ID: 29295972
[TBL] [Abstract][Full Text] [Related]
37. Protection of IgE-mediated allergic sensitization by active immunization with IgE loops constrained in GFP protein scaffold.
Chen SS; Barankiewicz T; Yang YM; Zanetti M; Hill P
J Immunol Methods; 2008 Apr; 333(1-2):10-23. PubMed ID: 18281056
[TBL] [Abstract][Full Text] [Related]
38. Accumulated immune complexes of IgE and omalizumab trap allergens in an in vitro model.
Hsu CL; Shiung YY; Lin BL; Chang HY; Chang TW
Int Immunopharmacol; 2010 Apr; 10(4):533-9. PubMed ID: 20139035
[TBL] [Abstract][Full Text] [Related]
39. Structure and dynamics of IgE-receptor interactions: FcεRI and CD23/FcεRII.
Sutton BJ; Davies AM
Immunol Rev; 2015 Nov; 268(1):222-35. PubMed ID: 26497523
[TBL] [Abstract][Full Text] [Related]
40. Generation of canine-human Fc IgE chimeric antibodies for the determination of the canine IgE domain of interaction with Fc epsilon RI alpha.
Hunter MJ; Vratimos AP; Housden JE; Helm BA
Mol Immunol; 2008 Apr; 45(8):2262-8. PubMed ID: 18187193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
